バイオテクノロジーニュース
-
December 18 , 2023
FDA approves enfortumab vedotin-ejfv (Padcev) with pembrolizumab (Keytruda) for locally advanced or metastatic urothelial cancer
詳しく見る -
December 15 , 2023
Harbour BioMed's Wholly-owned Subsidiary Nona Biosciences Enters into a Global License Agreement with Pfizer for HBM9033, an MSLN-Targeted Antibody-Drug Conjugate (ADC)
詳しく見る -
December 12 , 2023
SystImmune and Bristol Myers Squibb Announce a Global Strategic Collaboration Agreement for the Development and Commercialization of BL-B01D1
詳しく見る -
December 6 , 2023
South Africa's Aspen expands reach with $100M buy of Sandoz's Chinese business
詳しく見る -
December 1 , 2023
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
詳しく見る